Playback speed
10 seconds
Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Suneel Kamath
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Suneel Kamath
452 views
July 20, 2023
Login to view comments.
Click here to Login